Recommended Topic Related To:

Oncaspar

"The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pega"...

Oncaspar

Oncaspar

PATIENT INFORMATION

Serious Allergic Reactions

Patients should be informed of the possibility of serious allergic reactions. including anaphylaxis, and to immediately report any swellings or difficulty breathing.

Thrombosis

Patients should be advised to immediately report any severe headache. Arm or leg swelling, acute shortness of breath, and chest pain also should be reported immediately.

Pancreatitis

Patients should be advised to immediately report any severe abdominal pain.

Glucose Intolerance

Patients should be advised to report excessive thirst or any increase in the volume or frequency of urination.

Last reviewed on RxList: 3/2/2009
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.

Health Resources
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations